Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $116.23 | $23.64 | 391.62% | 219.30x | 55.32x | 14.74x | 17.80x | 1.59x | $106.92M | 0.87% | $705.78M | 6.70 | $12.46B | 1,588.61 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.16 | $8.08 | 211.50% | 119.81x | 56.25x | 7.08x | 14.34x | 1.03x | $39.15M | 1.19% | $220.58M | 1.69 | $3.24B | 71.42 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $75.79 | $17.03 | 344.96% | 70.83x | 64.84x | 6.99x | 9.04x | 1.81x | $182.84M | 3.11% | $654.15M | 8.43 | $5.75B | 47.91 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $219.72 | $79.13 | 177.66% | 36.02x | 32.58x | 6.11x | 21.71x | 1.24x | $793.95M | 2.70% | $1.35B | 10.14 | $30.68B | 26.01 | ||
| KRYS | KRYSTAL BIOTECH INC | $322.28 | $82.57 | 290.30% | 38.97x | 41.29x | 21.60x | 7.02x | 2.08x | $257.78M | 2.71% | $1.36B | 46.03 | $9.12B | 39.09 | ||
| VCEL | VERICEL CORP | $40.15 | $7.86 | 410.65% | 83.65x | 71.73x | 6.70x | 5.56x | 2.05x | $61.66M | 3.01% | $370.04M | 7.25 | $2.02B | 45.93 | ||
| RPRX | ROYALTY PHARMA PLC | $57.16 | $35.58 | 60.65% | 30.40x | 10.45x | 10.03x | 3.36x | 0.61x | $2.92B | 11.49% | $9.79B | 21.99 | $41.02B | 34.88 | ||
| HALO | HALOZYME THERAPEUTICS INC | $109.86 | $69.98 | 56.99% | 30.86x | 12.16x | 7.74x | 86.87x | 0.59x | $806.22M | 6.26% | $143.54M | 1.22 | $14.45B | 20.12 | ||
| TGTX | TG THERAPEUTICS INC | $54.29 | $22.05 | 146.23% | 17.63x | 54.63x | 9.63x | 13.76x | 1.96x | $17.39M | 0.23% | $604.08M | 4.26 | $8.58B | 61.62 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.18 | $18.33 | 212.02% | 150.47x | 19.76x | 3.25x | 1.75x | 1.00x | $738.18M | 6.67% | $6.32B | 32.68 | $14.38B | 37.29 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.99 | $7.48 | 33.47% | 10.52x | 9.18x | 4.34x | 2.73x | 0.92x | $82.01M | 13.87% | $217.65M | 3.68 | $449.42M | 5.81 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $235.67 | $177.29 | 32.93% | 15.44x | 9.22x | 3.24x | 3.19x | 0.63x | $1.62B | 10.87% | $4.80B | 75.98 | $18.07B | 11.18 | ||
| MDXG | MIMEDX GROUP INC | $4.59 | $1.25 | 266.59% | 114.75x | -26.47x | 1.91x | 3.10x | 1.25x | $44.50M | 6.56% | $216.00M | 1.46 | $550.41M | 24.13 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $504.73 | $145.91 | 245.91% | 29.12x | 26.37x | 10.17x | 6.32x | 2.19x | $3.80B | 2.96% | $20.25B | 79.81 | $123.76B | 22.49 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $302.96 | $84.43 | 258.82% | 30.09x | 32.07x | 20.92x | 6.24x | 2.28x | $130.62M | 2.15% | $967.52M | 48.22 | $6.16B | 22.10 | ||
| EXEL | EXELIXIS INC | $58.39 | $29.51 | 97.88% | 17.75x | 17.65x | 6.01x | 7.85x | 1.17x | $1.17B | 8.01% | $1.84B | 7.35 | $14.35B | 13.19 | ||
| ADMA | ADMA BIOLOGICS INC | $9.72 | $6.86 | 41.64% | 13.50x | 12.22x | 4.33x | 5.33x | 0.79x | $116.47M | 5.25% | $408.21M | 1.79 | $2.24B | 9.61 | ||
| UTHR | UNITED THERAPEUTICS CORP | $541.70 | $185.50 | 192.02% | 17.91x | 20.27x | 7.32x | 3.63x | 3.29x | $1.09B | 4.74% | $6.40B | 150.24 | $21.43B | 12.78 | ||
| TECH | BIO-TECHNE CORP | $72.40 | $16.01 | 352.10% | 61.88x | 34.85x | 9.29x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.38B | 32.73 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $735.20 | $420.83 | 74.70% | 17.53x | 13.11x | 4.87x | 2.39x | 0.93x | $3.76B | 4.98% | $31.71B | 308.48 | $75.94B | 13.21 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.64 | $29.60 | 33.94% | 12.62x | 9.51x | 2.39x | 2.31x | 0.75x | $354.90M | 15.45% | $999.24M | 17.25 | $1.91B | 6.83 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.19 | $1.37 | -12.83% | 8.50x | -2.68x | 1.47x | 1.57x | 0.47x | $19.58M | 28.40% | $44.20M | 0.76 | $20.57M | 2.69 | ||
| VCYT | VERACYTE INC | $45.81 | $11.53 | 297.18% | 31.81x | 23.55x | 6.52x | 2.65x | 2.67x | $165.99M | 4.53% | $1.39B | 17.36 | $3.42B | 24.50 | ||
| INCY | INCYTE CORP | $115.30 | $57.93 | 99.02% | 14.20x | 32.52x | 3.97x | 3.68x | 1.60x | $1.92B | 8.31% | $6.34B | 31.66 | $19.42B | 9.39 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.